StockNews.AI
RXST
StockNews.AI
3 hrs

Levi & Korsinsky Notifies Shareholders of RxSight, Inc.(RXST) of a Class Action Lawsuit and an Upcoming Deadline

1. RxSight faces a class action lawsuit alleging securities fraud. 2. The lawsuit targets alleged misleading financial statements with sales declines. 3. Affected investors can request lead plaintiff status until September 22, 2025. 4. Defendants allegedly overstated product demand and financial guidance. 5. Participation in the lawsuit requires no out-of-pocket costs for Class members.

8m saved
Insight
Article

FAQ

Why Very Bearish?

Class action lawsuits often negatively impact stock prices, especially if fraud is alleged. Historical examples like Theranos show lawsuits can severely erode investor confidence and stock value.

How important is it?

The allegation of securities fraud directly threatens investor confidence, hindering potential financial recovery for RXST.

Why Short Term?

The impact of lawsuits typically affects prices quickly as news spreads; historical trends show immediate sell-offs following such announcements.

Related Companies

NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ:RXST) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of RxSight, Inc. investors who were adversely affected by alleged securities fraud between November 7, 2024 and July 8, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=165256&wire=4

RXST investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) the Company was experiencing "adoption challenges" and/or structural issues resulting in declines in sales and utilization; (2) defendants had overstated the demand for RxSight's products; (3) as a result, RxSight was unlikely to meet its own previously issued financial guidance for fiscal year 2025; and (4) that, as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

WHAT'S NEXT? If you suffered a loss in RxSight, Inc. during the relevant time frame, you have until September 22, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 17th Floor

New York, NY 10004

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/levi--korsinsky-notifies-shareholders-of-rxsight-incrxst-of-a-class-action-lawsuit-and-an-upcoming-deadline-302547250.html

SOURCE Levi & Korsinsky, LLP

Related News